IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

DC Funds, LP

Q1 2025 Holdings

Filed 2025-05-14 | 3 holdings | $2.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Tscan Therapeutics Inc COM(TCRX)COM89854M101$869.4K630,00042.1%
Barinthus Biotherapeutics(BRNS)ADS91864C107$624.7K642,20430.2%
Werewolf Therapeutics Inc COM(HOWL)COM95075A107$572.7K589,10227.7%